Homepage / Programme Live /

Early-onset diabetes due to heterozygous RFX6 mutation: responsiveness to incretin-based therapy in a novel MODY subtype - (P-323)

Talk details

ePosters on Display (no oral presentation)
Monogenic and other forms of Diabetes
Early-onset diabetes due to heterozygous RFX6 mutation: responsiveness to incretin-based therapy in a novel MODY subtype (P-323)
M. VAISHNAV